№ files_lp_4_process_3_072365
File format: docx Character count: 6502 File size: 1893 KB
In this research article, the authors explore the use of doxorubicin-loaded exosomes as a method for inhibiting glioma cell proliferation, utilizing microfluidic technology for drug loading efficiency.
Year: 2026
Region / City: Hong Kong SAR
Subject: Neuroscience, Biomedical Sciences, Drug Delivery
Document Type: Research Article
Organization / Institution: City University of Hong Kong
Author: Abhimanyu Thakur, Rakesh Kumar Sidu, Heng Zou, Md Kowsar Alam, Mengsu Yang, Youngjin Lee
Target Audience: Researchers, Scientists, Medical Professionals
Period of Validity: N/A
Approval Date: N/A
Modification Date: N/A
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Abstract Submission Guidelines for the 3rd UK Microfluidics Conference, 19 June 2026
Year: 2026
Location: Manchester, United Kingdom
Topic: Microfluidics, Lab-on-Chip Technologies
Document Type: Conference Abstract Template
Organizing Institution: University of Manchester; Manchester Metropolitan University
Authors: Finn Box, Kirsty J. Shaw
Intended Audience: Conference participants in physics, chemistry, and bioengineering
Submission Deadline: Not specified
File Format: PDF, max 2 MB
Font Requirements: Aptos, 11 pt
Presentation Options: Oral, poster plus flash presentation, or either
Addendum to the submission for Dabrafenib and Trametinib for the treatment of paediatric low-grade and high-grade glioma with BRAF V600E mutation
Year: 2023
Region / City: Australia
Theme: Paediatric Oncology, Pharmacology
Document Type: Medical Submission
Organization / Institution: Novartis Pharmaceuticals Australia Pty Limited
Author: Novartis Pharmaceuticals Australia Pty Limited
Target Audience: Medical practitioners, oncologists, pharmacists, healthcare providers
Period of Validity: Not specified
Approval Date: 6 December 2023
Date of Amendments: Not specified
Supplementary Figures 1–2: Experimental Analyses of ROS Levels, Antioxidant Pathways, and Apoptosis in IDH1-Mutant U251 and Glioma Stem Cells
Year: Not specified
Scientific Field: Molecular Biology; Cancer Biology
Research Topic: Reactive oxygen species regulation and antioxidant response in IDH1-mutant glioma cells
Document Type: Supplementary figure captions
Experimental Models: U251 cells; GSC827; GSC923; TS603; mouse model
Genes / Proteins: IDH1; Nrf2 (NFE2L2); GCLC; GCLM; SLC7A11; caspase-3
Cellular Processes: Mitochondrial ROS production; apoptosis; antioxidant response
Experimental Methods: Western blot; MitoSOX immunofluorescence imaging; real-time PCR; ROS-Glo assay; GSH/GSSG assay; Annexin-PI flow cytometry
Treatments / Reagents: doxycycline (DOX); mannitol; catalase; MnTBAP; brusatol; N-acetylcysteine (NAC)
Genetic Manipulation: siRNA knockdown of Nrf2, GCLC, and GCLM
Measured Outcomes: ROS levels; mRNA expression; protein expression; glutathione balance; apoptotic cell fraction; mouse body weight
Statistical Indicators: ** p < 0.01; *** p < 0.001
Precision Neuro-Oncology: A Comprehensive Review of Molecular Diagnostics and Therapies in Glioma Care
Year: 2023
Region / City: N/A
Topic: Oncology, Neurology
Document Type: Review Article
Organization: Asian Oncology Research Journal
Author: Hadeel Mahdi Hussein
Target Audience: Scientific community, researchers, oncologists
Period of Action: N/A
Date of Approval: N/A
Date of Changes: N/A
Ethical Issues: None mentioned
References: Sufficient and recent
Language Quality: Suitable for scholarly communications
Context: Review article focusing on molecular diagnostics and therapies for glioma care in the field of neuro-oncology.
Topics: doxorubicin-loaded microfluidics glioma